Venous ulcers of the lower limb: Where do we stand?

ABSTRACT

Venous ulcers are the most common ulcers of the lower limb. It has a high morbidity and results in economic strain both at a personal and at a state level. Chronic venous hypertension either due to primary or secondary venous disease with perforator paucity, destruction or incompetence resulting in reflux is the underlying pathology, but inflammatory reactions mediated through leucocytes, platelet adhesion, formation of pericapillary fibrin cuff, growth factors and macromolecules trapped in tissue result in tissue hypoxia, cell death and ulceration. Duplex scan with colour flow is the most useful investigation for venous disease supplying information about patency, reflux, effects of proximal and distal compression, Valsalva maneuver and effects of muscle contraction. Most venous disease can be managed conservatively by leg elevation and compression bandaging. Drugs of proven benefit in venous disease are pentoxifylline and aspirin, but they work best in conjunction with compression therapy. Once ulceration is chronic or the patient does not respond to or cannot maintain conservative regime, surgical intervention treating the underlying venous hypertension and cover for the ulcer is necessary. The different modalities like sclerotherapy, ligation and stripping of superficial varicose veins, endoscopic subfascial perforator ligation, endovenous laser or radiofrequency ablation have similar long-term results, although short-term recovery is best with radiofrequency and foam sclerotherapy. For deep venous reflux, surgical modalities include repair of incompetent venous valves or transplant or transposition of a competent vein segment with normal valves to replace a post-thrombotic destroyed portion of the deep vein.

KEY WORDS

Compression therapy - surgery on veins - venous hypertension - venous ulcers

• 1 Karl T, Modic PK, Voss EU. Indications and results of VAC therapy treatments in vascular surgery-state of the art in the treatment of chronic wounds [in German]. Zentralbl Chir 2004;129 suppl 1:574- 9.
• 2 Collins R,Seraj S. Diagnosis and treatment of venous ulcers.Am Fam Physician 2010;81:989-96.
• 3 Hareendran A, Bradbury A, Budd J, Geroulakos G, Hobbs R, Kenkre J, et al.Measuring the impact of venous leg ulcers on quality of life. J Wound Care 2005;14:53-7.
• 4 Herber O, Schnepp W, Reiger M. A systematic review on the impact of leg ulceration on patients′ quality of life. Health QualLife Outcomes 2007;5:44-55.
• 5 González-Consuegra RV, Verdú J. Quality of life in people with venous leg ulcers: An integrative review. J Adv Nurs 2011;67:926- 44.
• 6 Word R. Medical and surgical therapy for advanced chronic venous insufficiency. Surg Clin North Am 2010;90:1195-214.
• 7 Malhotra SL. An epidemiological study of varicose veins in Indian railroad workers from the south and north of India, with special reference to the causation and prevention of varicose veins. Int J Epidemiol 1972;1:177-83.
• 8 Valencia IC, Falabella A, Kirsner RS, Eaglstein WH. Chronic venous insufficiency and venous leg ulceration. J Am Acad Dermatol 2001;44:401-21.
• 9 Etufugh CN, Phillips TJ. Venous ulcers.Clin Dermatol 2007;25:121-30.
• 10 Simon DA, Dix FP, McCollum C. Management of venous leg ulcers. BMJ 2004;328:1358-62.
• 11 van Gent WB, WilschutED, WittensC. Management of venous ulcer disease BMJ 2010;341:c6045.
• 12 vanBemmelen PS, Beach K, Bedford G, Strandness DE Jr. The mechanism of venous valve closure. Arch Surg 1990;125:617-9.
• 13 van Bemmelen PS, Bedford G, Beach K, Strandness DE. Quantitative segmental evaluation of venous valvular reflux with duplex ultrasound scanning.J Vasc Surg 1989;10:425-31.
• 14 Goldman MP, Fronek A. Anatomy and pathophysiology of varicose veins. J Dermatol Surg Oncol 1989;15:138-45.
• 15 Mozes G, Gloviczki P, Menawat SS, Fisher DR, Carmichael SW, Kadar A. Surgical anatomy for endoscopic subfascial division of perforating veins. J Vasc Surg 1996;24:800-8.
• 16 Browse NL, Burnand KG, Lea TM. Primary (non-thrombotic) deep vein incompetence.In: Browse NL, Burnand KG, Lea TM,editors. Diseases of the Veins: Pathology, Diagnosis, and Treatment. London: Edward Arnold; 1988. p. 253-68.
• 17 Caggiati A, Bergan JJ, Gloviczki P, Jantet G, Wendell-Smith CP, Partsch H. Nomenclature of the veins of the lower limbs: An international interdisciplinary consensus statement. J Vasc Surg 2002;36:416-22.
• 18 Somjen GM. Anatomy of the superficial venous system. Dermatol Surg 1995;21:35-45.
• 19 Michiels C, Arnould T, Thibaut-Vercruyssen R, Bouaziz N, Janssens D, Remacle J. Perfused human saphenous veins for the study of the origin of varicose veins: Role of the endothelium and of hypoxia. IntAngiol 1997;16:134-41.
• 20 Ascher E, Jacob T, Hingorani A, Tsemekhin B, Gunduz Y. Expression of molecular mediators of apoptosis and their role in the pathogenesis of lower-extremity varicose veins. J Vasc Surg 2001;33:1080-6.
• 21 Haardt B. A comparison of the histochemical enzyme pattern in normal and varicose veins.Phlebology1987;2:135-58.
• 22 Barber DA, Wang X, Gloviczki P, Miller VM. Characterization of endothelin receptors in human varicose veins. J Vasc Surg 1997;26:61-9.
• 23 Lowell RC, Gloviczki P, Miller VM. In vitroevaluation of endothelial and smooth muscle function of primary varicose veins. J Vasc Surg 1992;16:679-86.
• 24 Clarke GH, Vasdekis SN, Hobbs JT, Nicolaides AN. Venous wall function in the pathogenesis of varicose veins. Surgery 1992;111:402-8.
• 25 Sevitt S. The mechanisms of canalisation in deep vein thrombosis.J Pathol 1973;110:153-65.
• 26 Sevitt S. Organization of valve pocket thrombi and the anomalies of double thrombi and valve cusp involvement. Br J Surg 1974;61:641-9.
• 27 Glas-Greenwalt P, Dalton BC, Astrup T. Localization of tissue plasminogen activator in relation to morphological changes in human saphenous veins used as coronary artery bypass autografts. Ann Surg 1975;181:431-41.
• 28 Nicolaides AN, Hussein MK, Szendro G, Christopoulos D, Vasdekis S, Clarke H. The relationship of venous ulceration with ambulatory venous pressure measurements.J Vasc Surg 1993;17:414-9.
• 29 Thomas PR, Nash GB, Dormandy JA. White cell accumulation in dependent legs of patients with venous hypertension: A possible mechanism for trophic changes in the skin. Br Med J (Clin Res Ed)1988;296:1693-5.
• 30 Trent JT, Falabella A, Eaglstein WH, Kirsner RS.Venous ulcers: Pathophysiology and treatment options.OstomyWound Manage2005;51:38-54.
• 31 Cherian SM, Bobryshev YV, Inder SJ, Lord RS, AshwellWK. Dendritic cells in venous pathologies. Angiology1999;50:393-402.
• 32 Beebe HG, Bergan JJ, Bergqvist D, Eklof B, Eriksson I, Goldman MP, et al. Classification and grading of chronic venous disease in the lower limbs: A consensus statement. Eur J VascEndovascSurg 1996;12:487-91.
• 33 Perrin MJ. Surgery for deep venous reflux in lower limb (article in French).J MalVasc2004;29:73-87.
• 34 Holm J, Nilsson NJ, Scheersten T, Sivertsson R. Elective surgery for varicose veins. A simple method for evaluation of the patients.J CardiovascSurg (Torino) 1974;15:565-72.
• 35 Christopoulos D, Nicolaides AN, Szendro G. Venous reflux: Quantification and correlation with the clinical severity of venous disease. Br J Surg1988;75:352-6.
• 36 Raju S, Fredericks R. Venous obstruction: An analysis of one hundred thirty-seven cases with hemodynamic, venographic and clinical correlations. J VascSurg 1991;14:305-13.
• 37 Kistner RL, Kamida CB. Update on phlebography and varicography. DermatolSurg 1995;21:71-76.
• 38 Perrin M, Bolot JE, Genevois A, Hiltband B. Dynamic popliteal phlebography. Phlebologie 1988;41:429-40.
• 39 Abu-Own A, Scurr JH, Coleridge Smith PD. Effect of leg elevation on the skin microcirculation in chronic venous insufficiency. J Vasc Surg 1994;20:705-10.
• 40 Ruckley CV. Socioeconomic impact of chronic venous insufficiency and leg ulcers.Angiology 1997;48:67-9.
• 41 Phillips TJ, Machado F, Trout R, Porter J,Olin J,Falanga V. Prognostic indicators in venous ulcers. J Am AcadDermatol 2000;43:627-30.
• 42 Nelson EA,Mani R,Vowden K. Intermittent pneumatic compression for treating venous leg ulcers.Cochrane Database Syst Rev 2011(2);CD001899.
• 43 Raju S, Neglén P. Clinical practice. Chronic venous insufficiency and varicose veins.N Engl J Med 2009;360:2319-27.
• 44 deAraujo T, Valencia I, Federman DG, Kirsner RS. Managing the patient with venous ulcers. Ann Intern Med 2003;138:326-34.
• 45 O′Meara S, Cullum NA, Nelson EA. Compression for venous leg ulcers. Cochrane Database Syst Rev 2009(1);CD000265.
• 46 Fletcher A, Cullum N, Sheldon TA. A systematic review of compression treatment for venous leg ulcers.Br Med J 1997;315:576-80.
• 47 Cullum N, Nelson EA, Fletcher AW, Sheldon TA. Compression bandages and stockings for venous ulcers. Cochrane Database Syst Rev 2000(2);CD000265.
• 48 Jull A, Waters J, Arroll B. Pentoxifylline for treatment of venous leg ulcers: A systematic review. Lancet 2002;359:1550-4.
• 49 Robson MC, Cooper DM, Aslam R, Gould LJ, Harding KG, Margolis DJ, et al. Guidelines for the treatment of venous ulcers. Wound Repair Regen 2006;14:649-62.
• 50 Layton AM, Ibbotson SH, Davies JA, Goodfield MJ. Randomised trial of oral aspirin for chronic venous leg ulcers.Lancet 1994;344:164-5.
• 51 Wilkinson EA, Hawke CI. Does oral zinc aid the healing of chronic leg ulcers? A systematic literature review. Arch Dermatol 1998;134:1556-60.
• 52 Patel NM, Labropoulos N, Pappas PJ. Current management of venous Ulceration.Plastic and Reconstructive Surgery 2006;117, Suppl. issue 7S:254S-260S.
• 53 VuerstaekJD, VainasT, WuiteJ, NelemansP, NeumannMH, VeraartJC. State-of-the-art treatment of chronic leg ulcers: A randomized controlled trial comparing vacuum-assisted closure (V.A.C.) with modern wound dressings. J VascSurg2006;44:1029-37.
• 54 Ubbink DT, Westerbos SJ, Evans D, Land L, Vermeulen H. Topical negative pressure for treating chronic wounds. Cochrane Database Syst Rev 2008(3):CD001898.
• 55 Kranke P, Bennett M, Roeckl-Wiedmann I, Debus S. Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev 2004(2):CD004123.
• 56 Palfreyman S, Nelson EA, Michaels JA. Dressings for venous leg ulcers: Systematic review and meta -analysis. [published correction appears inBMJ 2007;335(7617):0. BMJ 2007;335:244-8.
• 57 Nelson EA, Bell-Syer SE, Cullum NA. Compression for preventing recurrence of venous ulcers.Cochrane Database Syst Rev 2000(4);CD002303.
• 58 Tallman P, Muscare E, Carson P, Eaglstein WH, Falanga V. Initial rate of healing predicts complete healing of venous ulcers. Arch Dermatol 1997;133:1231-4.
• 59 Lok C, Paul C, Amblard P, Bessis D, Debure C, Faivre B, et al. EMLA cream as a topical anesthetic for the repeated mechanical debridement of venous leg ulcers: A double-blind, placebo-controlled study. J Am Acad Dermatol 1999;40:208-13.
• 60 Falabella AF, Carson P, Eaglstein WH, Falanga V. The safety and efficacy of a proteolytic ointment in the treatment of chronic ulcers of the lower extremity.J Am Acad Dermatol. 1998;39:737- 40.
• 61 Dumville JC, Worthy G, Bland JM, Cullum N, Dowson C, Iglesias C, et al.; for the Ven US II team. Larval therapy for leg ulcers (VenUS II): Randomised controlled trial. BMJ 2009;338:b773.
• 62 Soares MO, Iglesias CP, Bland JM, Cullum N, Dumville JC, Nelson EA, et al.; for the VenUS II team. Cost effectiveness analysis of larval therapy for leg ulcers. BMJ 2009;338:b825.
• 63 Jones JE, Nelson EA. Skin grafting for venous leg ulcers. Update in Cochrane Database Syst Rev 2007(2);CD001737.
• 64 Barwell JR, Davies CE, Deacon J, Harvey K, Minor J, Sassano A,et al. Comparison of surgery and compression with compression alone in chronic venous ulceration (ESCHAR study): Randomised controlled trial. Lancet 2004;363:1854-9.
• 65 Falanga V, Margolis D, Alvarez O, Auletta M, Maggiacomo F, Altman M,et al. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Human Skin Equivalent Investigators Group. Arch Dermatol 1998;134:293-300.
• 66 Masuda EM, Kistner RL. Long-term results of venousvalve reconstruction: A four- to twenty-one-year follow-up. J VascSurg 1994;19:391-403.
• 67 DePalma RG. Management of incompetent perforators: Conventional techniques.In: Gloviczki P, Yao JS, editors. Handbook of Venous Disorders: Guidelines of the American Venous Forum. 2 nd ed. New York, NY: Arnold;2001. p. 384-90.
• 68 Linton RR. The communicating veins of the lower leg and the operative technique for their ligation. Ann Surg 1938;107:582-93.
• 69 Pierik EG, van Urk H, Hop WC, Wittens CH. Endoscopic versus open subfascial division of incompetent perforating veins in the treatment of venous leg ulceration: A randomized trial. J VascSurg 1997;26:1049-54.
• 70 Hauer G. Endoscopic subfascial discussion of perforating veins-preliminary report. Vasa 1985;14:59-61.
• 71 Coleridge Smith P. Foam and liquid sclerotherapy for varicose veins. Phlebology2009;24(Suppl 1): 62-72.
• 72 Roland L, Dietzek AM. Radiofrequency ablation of the great saphenous vein performed in the office: Tips for better patient convenience and comfort and how to perform it in less than an hour.Perspect Vasc Surg Endovasc Ther 2007;19:309-14.
• 73 Ugur O. Endovenous laser ablation of incompetent perforator veins: A new technique in the treatment of chronic venous disease. CardiovascIntervent Radiol 2009;32:1067-70.
• 74 Kistner RL, Eklof B,Masuda EM. Deep venous valve reconstruction. Cardiovasc Surg 1995;3:129-40.
• 75 Raju S, Fredericks RK, Negelen PN, Bass JD.Durability of venous valve reconstruction techniques for "primary" and postthrombotic reflux. J Vasc Surg1996;23:357-67.
• 76 Rasmussen LH, Lawaetz M, Bjoern L, Vennits B, Blemings A, Eklof B. Randomized clinical trial comparing endovenous laser ablation, radiofrequency ablation, foam sclerotherapy and surgical stripping for great saphenous varicose veins. Br J Surg 2011;98:1079-87.